mail
versión imprimible
 
 

ADC and Radiopharmaceuticals Pharma and Biotech Partnering Summit

Evvnt Promotion / evvnt
Archivo
-
09.09.2024 - 10.09.2024  Revere Hotel Boston Common, 200 Stuart Street, 02116 Boston, Massachusetts, USA
Time: 9:00 AM - 5:00 PM
 
Temas de la conferencia
Major moves in the pharma and biotech partnering are reshaping the landscape. With AbbVie's acquisition of ImmunoGen leading the charge in 2023, and Merck's licensing deal with Daiichi reaching unprecedented heights across three ADC programs, the market frenzy surrounding ADCs has never been hotter.

Even Eli Lilly's acquisition of Mablink, despite lacking clinical programs, underscores the feverish pace of activity in the field, breaking traditional pharma partnering trends.
Organizador profesional (PCO)
Hanson Wade
Observaciones
URL:
Brochure: https://go.evvnt.com/2481194-3?pid=4832

Speakers: Adrianne Wong, Director, Oncology Search and Evaluation, Global Business Development, Daiichi Sankyo, Albert Hsia, Executive Director, Business Development, Merck, and more
 

Información e inscripción:

https://go.evvnt.com/2481194-2?pid=4832
Ms. Karina Bikerniece
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
Two Day Attendance and Access to Partnering Portal - Biotech, Pharma and Investors: USD 2999.00, Two Day Attendance and Access to Partnering Portal - Academics: USD 2399.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Anästhesie in Entwicklungsländern e. V.Österreichische Gesellschaft für Public HealthCharité International AcademynewTreeEuropean Health Forum GasteinHelix - Forschung & Beratung WienAGEM - Arbeitsgemeinschaft Ethnologie und MedizinÄrzte der Welt